Are parents' views about their child's treatment for juvenile idiopathic arthritis (JIA) related to evaluations of their child's quality of life (QoL)? – SPARKS CHARM study

por Mulligan, K, Etheridge, A, Kassoumeri, L, Woo, P, Wedderburn, LR, Newman, S
Publicado 2008

Can inflammatory markers predict response to methotrexate in JIA? Results from the CHARM study

por Moncrieffe, H, Holzinger, D, Ursu, S, Patrick, F, Kassoumeri, L, Roth, J, Wedderburn, LR
Publicado 2011

Methotrexate in childhood arthritis: effects on gene expression

por Moncrieffe, H, Ursu, S, Etheridge, A, Kassoumeri, L, Stansfield, A, Jina, N, Wedderburn, L
Publicado 2008

PReS-FINAL-1017: Antioxidant superoxide dismutase activity is elevated in jia but not associated with disease activity

por Radziszewska, A, Rowden, C, Suffield, L, Ursu, S, Kassoumeri, L, Wedderburn, LR, Ioannou, Y
Publicado 2013

PReS-FINAL-1009: Antioxidant superoxide dismutase activity is paradoxically normal in juvenile systemic lupus erythematosus

por Radziszewska, A, Rowden, C, Suffield, L, Ursu, S, Kassoumeri, L, Wedderburn, LR, Ioannou, Y
Publicado 2013

Investigating which variables from the core outcome variables in juvenile idiopathic arthritis (JIA) are the best predictors of classification as a responder to treatment with meth...

por Hirani, SP, Kassoumeri, L, Mulligan, K, Ruperto, N, Woo, P, Wedderburn, LR, Newman, SP
Publicado 2008

Characterising inflammatory markers in two childhood autoimmune diseases (JIA and JDM) pre and post methotrexate

por Ursu, S, Moncrieffe, H, Varsani, H, Hamaoui, RHB, Beard, L, Kassoumeri, L, Patrick, F, Wedderburn, LR
Publicado 2011

Investigating the use of a limited core outcome variable set for the classification of response following methotrexate treatment in juvenile idiopathic arthritis (JIA)

por Hirani, SP, Kassoumeri, L, Etheridge, A, Mulligan, K, Ruperto, N, Woo, P, Wedderburn, L, Newman, SP
Publicado 2008